We also identified that salinomycin reduced the expression of prostate cancer oncogenes, MYC, AR and ERG, which are known to have antioxidative properties (Tam et al, 2003; Benassi et al, 2006; Pinthus et al, 2007; Swanson et al, 2011). Here, AR is linked to prostate carcinoma.